Cost-effectiveness analysis of isolation strategies for asymptomatic and mild symptom COVID-19 patients
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Cost-effectiveness analysis of isolation strategies for asymptomatic and mild symptom COVID-19 patients ; volume:21 ; number:1 ; day:9 ; month:11 ; year:2023 ; pages:1-9 ; date:12.2023
Cost effectiveness and resource allocation ; 21, Heft 1 (9.11.2023), 1-9, 12.2023
- Urheber
-
Suthutvoravut, Unyaporn
Kunakorntham, Patratorn
Semayai, Anchisatha
Tansawet, Amarit
Oraluck Pattanaprateep
Piebpien, Pongsathorn
Numthavaj, Pawin
Thakkinstian, Ammarin
Atiksawedparit, Pongsakorn
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12962-023-00497-x
- URN
-
urn:nbn:de:101:1-2024012911263028775410
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:38 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Suthutvoravut, Unyaporn
- Kunakorntham, Patratorn
- Semayai, Anchisatha
- Tansawet, Amarit
- Oraluck Pattanaprateep
- Piebpien, Pongsathorn
- Numthavaj, Pawin
- Thakkinstian, Ammarin
- Atiksawedparit, Pongsakorn
- SpringerLink (Online service)
Ähnliche Objekte (12)
Asymptomatic recurrence detection and cost-effectiveness in urothelial carcinoma
COVID-19 testing protocols to guide duration of isolation: a cost-effectiveness analysis
Cost-effectiveness of osteoporosis screening and biases in cost-effectiveness analyses
Cost-effectiveness analysis for clinicians
The probability of cost-effectiveness
Dealing with Bad Risk in Cost-Effectiveness Analysis: The Cost-Effectiveness Risk-Aversion Curve
Evaluating Cost-Effectiveness of Antiretroviral Therapy over Time: A Cohort and Cost-Effectiveness Study
Vancomycin-resistant enterococci (VRE) screening and isolation in the general medicine ward: a cost-effectiveness analysis
Cost-Effectiveness of Targeted Reemployment Bonuses
Cost-effectiveness and algorithmic decision-making
Challenges in synthesising cost-effectiveness estimates
Online Cost-Effectiveness ANalysis (OCEAN): a user-friendly interface to conduct cost-effectiveness analyses for cervical cancer
Asymptomatic recurrence detection and cost-effectiveness in urothelial carcinoma
COVID-19 testing protocols to guide duration of isolation: a cost-effectiveness analysis
Cost-effectiveness of osteoporosis screening and biases in cost-effectiveness analyses
Cost-effectiveness analysis for clinicians
The probability of cost-effectiveness
Dealing with Bad Risk in Cost-Effectiveness Analysis: The Cost-Effectiveness Risk-Aversion Curve
Evaluating Cost-Effectiveness of Antiretroviral Therapy over Time: A Cohort and Cost-Effectiveness Study
Vancomycin-resistant enterococci (VRE) screening and isolation in the general medicine ward: a cost-effectiveness analysis
Cost-Effectiveness of Targeted Reemployment Bonuses
Cost-effectiveness and algorithmic decision-making
Challenges in synthesising cost-effectiveness estimates
Online Cost-Effectiveness ANalysis (OCEAN): a user-friendly interface to conduct cost-effectiveness analyses for cervical cancer
Asymptomatic recurrence detection and cost-effectiveness in urothelial carcinoma
COVID-19 testing protocols to guide duration of isolation: a cost-effectiveness analysis
Cost-effectiveness of osteoporosis screening and biases in cost-effectiveness analyses
Cost-effectiveness analysis for clinicians
The probability of cost-effectiveness
Dealing with Bad Risk in Cost-Effectiveness Analysis: The Cost-Effectiveness Risk-Aversion Curve
Evaluating Cost-Effectiveness of Antiretroviral Therapy over Time: A Cohort and Cost-Effectiveness Study
Vancomycin-resistant enterococci (VRE) screening and isolation in the general medicine ward: a cost-effectiveness analysis
Cost-Effectiveness of Targeted Reemployment Bonuses
Cost-effectiveness and algorithmic decision-making
Challenges in synthesising cost-effectiveness estimates